ANDA 40139, held by Watson Labs. Acetaminophen; Propoxyphene Hydrochloride.
As of Nov 16, 2026, ANDA 40139 (Propoxyphene Hydrochloride And Acetaminophen), held by Watson Labs, was first approved by FDA on Dec 16, 1996, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 16, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Propoxyphene Hydrochloride And Acetaminophen650MG;65MG ยท tablet;oral | Acetaminophen; Propoxyphene Hydrochloride | Discontinued |
| Mar 27, 2002 | Supplement 7Manufacturing | Approved | None posted |
| Apr 18, 2001 | Supplement 4Manufacturing | Approved | None posted |
| Apr 18, 2001 | Supplement 5Manufacturing | Approved | None posted |
| Mar 21, 2000 | Supplement 6Manufacturing | Approved | None posted |
| Aug 21, 1998 | Supplement 3Manufacturing | Approved | None posted |
| Jul 8, 1997 | Supplement 1Manufacturing | Approved | None posted |
| Dec 16, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters